Understanding the diverse roles of glucose and insulin – energy supply and modulators of signalling cascades – and delineating glucose and insulin signalling pathways should facilitate prevention and drug discovery research to control obesity, diabetes and cancer. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.